Søvnforstyrrelse (- 15, 2, 95% CI - 19, 37, - 10, 94; p < 0, 0001), søvnmængde (0, 7 time, 95% CI 0, 49, 0, 94; p < 0, 0001), søvnsufficiens (18, 6, 95% CI 13, 77, 23, 45; p < 0, 0001) og somnolens om dagen (- 7, 5, 95% CI - 10, 86, - 4, 23; p < 0, 0001) Et rebound fænomen i forbindelse med seponering af ropinirol kan ikke udelukkes.
The adjusted treatment differences between ropinirole and placebo were: sleep disturbance (-15.2, 95% CI -19.37, -10.94; p < 0.0001), sleep quantity (0.7 hours, 95% CI 0.49, 0.94); p < 0.0001), sleep adequacy (18.6, 95% CI 13.77, 23.45; p < 0.0001) and daytime somnolence (-7.5, 95% CI -10.86, -4.23; p < 0.0001).